Opportunity Information: Apply for RFA DA 13 001
Apply for RFA DA 13 001
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Feb 6, 2012 and posted on Feb 6, 2012.
- Applicants must submit their applications by Aug 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: Private institutions of higher education Special district governments Small businesses County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments State governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33)" (Funding Opportunity Number RFA-DA-13-001) is a National Institutes of Health (NIH) discretionary grant focused on services research during a period of major health system change. Its main purpose is to support rigorous, objective research that can track and explain how health care reform influences the real-world organization, delivery, access, and outcomes of drug use prevention services, addiction treatment services, and related HIV and viral hepatitis services. In practical terms, the NIH is looking for studies that do more than describe reform on paper; the emphasis is on careful research that can monitor what is actually changing in communities, clinics, treatment systems, and prevention programs, and what those changes mean for patients and populations.
This announcement uses a phased innovation mechanism (R21/R33), which is designed to help projects move from early-stage planning and feasibility work into a larger, more definitive study once feasibility is demonstrated. The first phase is the R21, which can support up to two years of activities such as developing partnerships with service systems, refining research questions, building data infrastructure, testing recruitment and measurement approaches, piloting analytic methods, and running feasibility or proof-of-concept studies. If the project meets predefined milestones and shows it is ready to scale, it may transition into the R33 phase, which can provide up to four additional years of support for expanded research. Even with the possibility of moving into the larger phase, the overall project period for any application under this FOA cannot exceed five years, meaning the planning phase and the expanded phase together must fit within that cap.
The topic focus is explicitly tied to health care reform and its ripple effects across prevention, treatment, and infectious disease services that intersect with substance use. This includes how reforms may shift financing and reimbursement, alter insurance coverage, change provider networks, reorganize service delivery models, integrate or separate behavioral health and general medical care, and influence the availability and quality of HIV and viral hepatitis prevention and care within addiction-related settings. The intent is to generate evidence that helps stakeholders understand which reform-driven changes improve service access and outcomes, which changes create gaps or unintended consequences, and how systems can respond in a way that protects and improves public health.
From an administrative standpoint, this is a grant (Funding Instrument Type: Grant) in the Education and Health activity category, listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The program does not require cost sharing or matching funds. The opportunity was posted on February 6, 2012, with an original and current closing date of August 22, 2012, and it was archived on September 22, 2012. The estimated total funding amount is $1,500,000, and the listed award ceiling is $150,000 (as presented in the source data), which signals a relatively constrained upper limit per award under the terms shown, even though the mechanism includes a multi-phase structure.
Eligibility is broad across public, private, nonprofit, and governmental entities that can carry out health services research. Eligible applicants include private and public institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profits), and a wide range of government units such as state governments, county governments, city or township governments, special district governments, and independent school districts. The FOA also identifies additional eligible groups such as faith-based or community-based organizations, historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, federally recognized and other tribal governments and tribal organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, it clearly excludes foreign institutions: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Overall, the opportunity is aimed at building a stronger evidence base about how health care reform affects the systems that prevent drug use, treat addiction, and address HIV and viral hepatitis in populations touched by substance use. The phased design is meant to reduce risk by funding careful early development work first, then supporting larger-scale research only when the project demonstrates it can be executed successfully. The official NIH announcement and details were provided via the linked NIH grants page (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-001.html), with technical access support directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the source.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33)." The Funding Opportunity Number (FOA) is RFA-DA-13-001.
Which agency is offering this funding?
This is a National Institutes of Health (NIH) discretionary grant opportunity.
What is the main purpose of this FOA?
The FOA is intended to support rigorous, objective services research that tracks and explains how health care reform affects the real-world organization, delivery, access, and outcomes of drug use prevention services, addiction treatment services, and related HIV and viral hepatitis services. The focus is on what is actually changing in communities and service systems, not just policy descriptions.
What types of services and outcomes does the research need to address?
The scope includes drug use prevention, addiction treatment, and HIV and viral hepatitis services that intersect with substance use. Studies should be designed to monitor real-world changes and what they mean for patients and populations, including potential improvements, gaps, or unintended consequences.
How is health care reform expected to relate to the research topics?
The FOA explicitly ties the research focus to health care reform and its ripple effects, such as shifts in financing and reimbursement, changes in insurance coverage, changes in provider networks, reorganization of service delivery models, and integration or separation of behavioral health and general medical care. It also includes how these reforms influence availability and quality of HIV and viral hepatitis prevention and care within addiction-related settings.
What is the funding mechanism used for this opportunity?
This announcement uses a phased innovation mechanism (R21/R33), which supports early-stage planning/feasibility work first and then allows a transition to a larger study phase if the project meets predefined milestones.
What is the R21 phase intended to support?
The R21 phase can support up to two years of activities such as developing partnerships with service systems, refining research questions, building data infrastructure, testing recruitment and measurement approaches, piloting analytic methods, and conducting feasibility or proof-of-concept studies.
What is the R33 phase intended to support?
If the project demonstrates feasibility and meets predefined milestones, it may transition into the R33 phase, which can provide up to four additional years of support for expanded, more definitive research.
Does an award automatically move from R21 to R33?
No. Transition to the R33 phase depends on meeting predefined milestones and demonstrating readiness to scale beyond feasibility work, as described in the FOA overview.
What is the maximum total project period under this FOA?
The overall project period for an application under this FOA cannot exceed five years total, meaning the combined R21 and R33 time must fit within that five-year cap.
What is the funding instrument type?
The funding instrument type is a grant.
What is the activity category for this funding opportunity?
The activity category is Education and Health.
What CFDA program is associated with this opportunity?
The opportunity is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.
Is cost sharing or matching required?
No. The program does not require cost sharing or matching funds.
How much total funding is estimated for this FOA?
The estimated total funding amount listed is $1,500,000.
What is the award ceiling shown in the source information?
The listed award ceiling is $150,000 (as presented in the source data). The source notes this suggests a relatively constrained upper limit per award under the terms shown, even though the mechanism includes a multi-phase structure.
When was this opportunity posted, and what were the closing dates?
The opportunity was posted on February 6, 2012. The original and current closing date is August 22, 2012. It was archived on September 22, 2012.
Is this FOA still open for applications?
No. Based on the provided information, the closing date was August 22, 2012, and the FOA was archived on September 22, 2012.
Who is eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (including small businesses and other for-profits); and many government entities (including state, county, and city or township governments, special district governments, and independent school districts).
Are community-based and faith-based organizations eligible?
Yes. The FOA identifies faith-based or community-based organizations as eligible applicants.
Are minority-serving institutions and tribal entities eligible?
Yes. The FOA lists eligibility for historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, federally recognized and other tribal governments and tribal organizations, and regional organizations.
Are U.S. territories or possessions eligible?
Yes. The FOA includes U.S. territories or possessions among eligible applicants.
Are federal agencies eligible to apply?
Yes. The FOA states that eligible federal agencies may apply.
Are foreign institutions or non-U.S. entities eligible?
No. The FOA explicitly excludes foreign institutions. Non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
What kind of research approach is NIH emphasizing?
The FOA emphasizes careful, rigorous research that monitors and explains real-world change during health care reform, including how services are organized and delivered in practice and how those changes affect access and outcomes. The intent is to generate evidence about what improves public health and what creates gaps or unintended consequences.
Where can applicants find the official NIH announcement?
The official NIH announcement is provided via the NIH grants page at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-001.html.
Where is technical access support directed?
Technical access support is directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the source information.
Browse more opportunities from the same category: Education Health
Next opportunity: National Forum for State and Territorial Chief Executives
Previous opportunity: Ancillary Domain Validation Patient Reported Outcomes Measurement Information System (PROMIS) Studies (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers of Excellence in Symptom Science (P30) Apply for RFA NR 12 006 Funding Number: RFA NR 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $480,000 |
| Centers of Excellence in Symptom Science Building Research Teams for the Future (P20) Apply for RFA NR 12 009 Funding Number: RFA NR 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 12 001 Funding Number: RFA LM 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award (K22) Apply for PAR 12 121 Funding Number: PAR 12 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 12 127 Funding Number: PA 12 127 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 12 128 Funding Number: PA 12 128 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 12 129 Funding Number: PA 12 129 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 12 130 Funding Number: PA 12 130 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Research to Assist Informal Caregivers in Assessing and Managing Symptoms in Individuals with Alzheimers Disease (R01) Apply for RFA NR 12 011 Funding Number: RFA NR 12 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Translational Research at the Aging/Cancer Interface (TRACI) (R21) Apply for PA 12 135 Funding Number: PA 12 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Translational Research at the Aging/Cancer Interface (TRACI) (R01) Apply for PA 12 136 Funding Number: PA 12 136 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Detection and Prevention of Mild Cognitive Impairment (R01) Apply for RFA NR 12 010 Funding Number: RFA NR 12 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) Apply for PAS 12 122 Funding Number: PAS 12 122 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Technology Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01) Apply for PA 12 117 Funding Number: PA 12 117 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technology Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34) Apply for PA 12 118 Funding Number: PA 12 118 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 12 145 Funding Number: PAR 12 145 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 12 144 Funding Number: PAR 12 144 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol associated Cancers (R01) Apply for PA 12 146 Funding Number: PA 12 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol associated Cancers (R21) Apply for PA 12 147 Funding Number: PA 12 147 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Senior Scientist Research Award (K05) Apply for PA 12 048 Funding Number: PA 12 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.